by Medindia Content Team on  April 12, 2006 at 6:17 PM Cancer News
Roche Rolls Out Lung Cancer Drug In India
Indian Pharmaceutical Industry is richer with the availability of one more beneficial drug, used in the treatment of lung cancer. Tarceva, the name by which the drug is known is produced by the Swiss-pharma company Roche, and will now be available in India

This is certainly a fresh lease of life to nearly 1, 60, 000 lung cancer patients in India. Tarceva has been available in the US since 2004 and in the European Union since 2005. This drug is normally administered to patients with advanced lung cancer, who have not responded well to even one chemotherapy treatment.

Tarceva is an established effective treatment for lung cancer, and perhaps the only epidermal growth factor receptor-inhibitor, to offer high survival rates in the treatment of lung cancer

Most Popular on Medindia